US Archives - Page 48 of 137 - European Medical Journal

Gene Assay May Guide Chemo Use in Early NSCLC: ASCO 2025

A gene-based assay may help guide adjuvant chemotherapy decisions in early-stage non-squamous non-small cell lung cancer (NSCLC), according to interim results from a randomized clinical trial presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.

Surgery Cuts Brain Abscess Death Risk and Favored Over Drug Treatment

A new nationwide study finds that neurosurgical intervention significantly reduces the risk of death and complications in adult patients with brain abscess compared to non-operative care, underscoring the importance of early surgical evaluation.

Fitness Tech Vibration Devices May Trigger Itch

Whole body vibration (WBV) training may trigger itch and erythema in a significant portion of users, with side-to-side vibration devices posing a higher risk, according to a new multicenter study.

Bridging the Catatonia Knowledge Gap in Clinics

Catatonia remains a misunderstood neuropsychiatric condition, and a new evidence-based review challenges ten prevailing myths that may delay diagnosis and compromise patient outcomes.

Phase III Data Examines New Regimen in BRAF-Mutant Colorectal Cancer: ASCO 2025

Results from an international Phase III clinical trial presented at the 2025 ASCO Annual Meeting evaluate a treatment regimen combining encorafenib and cetuximab with mFOLFOX6 chemotherapy in patients with previously untreated BRAF V600E-mutant metastatic colorectal cancer (mCRC).

Albuterol–Budesonide Combo Inhaler To Lower Asthma Risk

A large randomized trial has found that as-needed use of a fixed-dose combination of albuterol and budesonide significantly reduces the risk of severe asthma exacerbations compared to albuterol alone in patients with mild asthma.

Uncovering Who Carries Salmonella Long-Term

A new study has identified key risk factors that may predispose individuals to long-term shedding (LTS) of non-typhoidal Salmonella (NTS), offering insights into why certain patients remain contagious weeks after initial infection.

Chronic Back Pain: Which Therapies Last?

Cognitive behavioral therapy (CBT) and mindfulness may offer sustained reductions in pain and disability for adults with non-specific chronic low back pain, according to a new systematic review and meta-analysis of 75 randomized controlled trials encompassing over 15,000 participants.

Mohs Surgery Alone Outperforms Combo With Photodynamic Therapy

New research suggests that Mohs micrographic surgery (MMS) alone may lead to lower recurrence rates than when combined with photodynamic therapy (PDT) in treating locally advanced basal cell carcinoma (laBCC), particularly in non-aggressive subtypes.

Sustainable Infection Control: SHEA 2025

The Society for Healthcare Epidemiology of America (SHEA) Spring 2025 Conference, held in Champions Gate, Florida from April 27ᵗʰ to 30ᵗʰ…